The role of antibody class and target on subepidermal blistering disease phenotype and management

Read full text Summarise with VIRAT
Authors: Raphaella A. LAMBERT, Christiaan H Noot, Zachary Frost, Zachary Ney, Annika M. Hansen, Areeba AHMED, Hannah Verma, Grace Rabinowitz, Nicholas Gulati, Shreya A. Sreekantaswamy, John J. Zone, Jamie L W Rhoads
+3 more Christopher M. Hull, Jónas A. Aðalsteinsson, Zachary H. Hopkins
Cited by: 0
References: 116

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Subepidermal blistering diseases are driven by autoantibodies targeted to the basement membrane zone. These autoantibodies can stem from multiple antibody classes (e.g., IgE, IgG, IgM, IgA) and differing antibody classes and antibody targets can impact disease phenotype and potentially management. Despite significant advances, there remains a paucity of data and funding for further elucidating subepidermal blistering disease pathophysiology and the impact this has on management. This review highlights current understanding of subepidermal blistering disease antibody targets, classes, and the impact these have on disease clinical phenotype and management. Highlighted conditions will include bullous pemphigoid, mucous membrane pemphigoid, including ocular cicatricial pemphigoid, linear IgA disease, and epidermolysis bullosa acquisita.

Fields of Study & Subjects

Autoimmune Bullous Skin Diseases Skin and Cellular Biology Research Celiac Disease Research and Management

Publication details

Journal / source
Italian Journal of Dermatology and Venereology
Volume
161
Issue
3
Pages
222–235
Publication date
16 March 2026
Language
EN